Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 T24-p , S253-p , S316-p
CDK1 S246-p
ERK1 S326-p
ERK2 S246-p , S284-p , S295-p , S326-p , S413-p , S415-p , S429-p , S467-p , S475-p
P38A S284-p , S295-p , S326-p , S467-p , S475-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 T24-p , S253-p
CDK1 S246-p
CDK2 S246-p
CDK5 S246-p
ERK2 S246-p , S413-p , S415-p , S429-p , S467-p , S475-p , T557-p
P38A S413-p , S429-p , S467-p , S475-p , T557-p
Phosphatases, in vitro:
DUSP6 S253-p
Regulatory protein:
Akt1 S253-p
Akt2 S253-p
BAG1 S253-p
BAG4 S253-p
CTLA-4 S253-p
DICER1 S253-p
DUSP6 S253-p
GRB10 S253-p
INSR T24-p
LIMS1 S253-p
LIMS1 S253-p
LPIN1 S253-p
PDK1 S253-p
PTEN T24-p
RICTOR T24-p
Sin1 T24-p
SIRT6 S246-p
TORC2 S253-p
TSC1 T24-p
VEGF S253-p
Treatment:
4-HT S253-p
anti-CD3/CD28 S253-p
EGF S253-p
fasting T24-p , S253-p
free_fatty_acids S246-p
H2O2 S253-p
hepatitis C virus expression S253-p
IGF-1 T24-p , S253-p , S316-p
IGFBP-4 S253-p
IL-3 S253-p
insulin T24-p , S253-p , S295-p , S300-p , S316-p , S326-p
KCl_withdrawal S246-p
KU-0063794 T24-p
L803-mts S253-p
LY294002 S326-p
miRNA S253-p
nocodazole S246-p
PDGF S253-p
rapamycin T24-p , S253-p
refeeding T24-p , S253-p
rosiglitazone T24-p , S246-p
seliciclib S246-p
serum T24-p
TGF-beta S253-p
Trametinib S326-p
U0126 S253-p , S295-p
Wnt S253-p
wortmannin T24-p , S253-p